Liver Cirrhosis
📧 Sign up to get email alerts when something new happens for Liver Cirrhosis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2009-02-25FDA Approved: SPIRONOLACTONE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for Spironolactone submitted by Mylan Pharmaceuticals Inc.
-
CLINICAL_TRIALS trial_result · 2009-02-24Clinical Trial Update: Muscle Tissue Oxygenation in Patients With Decompensated Liver Cirrhosis
A clinical trial examining muscle tissue oxygenation in patients with decompensated liver cirrhosis, sponsored by the University of Regensbu…
-
FDA approval · 2009-02-20FDA Approved: FUROSEMIDE — Supplemental Application (Solco Healthcare LLC)
The FDA approved a supplemental application for furosemide from Solco Healthcare LLC, adding a new manufacturing source for the product.
-
CLINICAL_TRIALS research · 2009-01-30Clinical Trial Update: Autologous Bone Marrow Mononuclear Cells in Liver Cirrhosis [Phase 1]
Phase 1 clinical trial evaluating autologous bone marrow mononuclear cells for liver cirrhosis due to chronic hepatitis C; sponsored by Univ…
-
CLINICAL_TRIALS trial_result · 2009-01-12Clinical Trial Update: Satavaptan Dose-Ranging Study in the Prevention of Ascites [Phase 2]
Phase 2 dose-ranging study of satavaptan for prevention of ascites in liver cirrhosis has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2009-01-01Clinical Trial Update: Prevention of Bleeding in Patient With Cirrhosis Undergoing Dental Extraction [NA]
A completed clinical trial evaluating methods to prevent bleeding in patients with liver cirrhosis undergoing dental extraction.
-
CLINICAL_TRIALS trial_result · 2008-12-11Clinical Trial Update: PEG-Intron Plus Rebetol Treatment of Chronic Hepatitis C Subjects Who Failed Response to Alpha-Interferon Plus Ribavirin (Study P02370) [Phase 3]
A Phase 3 trial (Study P02370) evaluated pegylated interferon alfa-2b (PEG-Intron) plus ribavirin (Rebetol) in chronic hepatitis C patients …
-
CLINICAL_TRIALS trial_result · 2008-12-01Clinical Trial Update: A Randomized Controlled Trial Comparing Band Ligation and Cyanoacrylate Injection for Esophageal Varices [Phase 4]
Phase 4 randomized trial comparing band ligation versus cyanoacrylate injection to treat esophageal varices in patients with liver disease; …
-
CLINICAL_TRIALS trial_result · 2008-08-14Clinical Trial Update: TIPS Versus Portacaval Shunt for Acute Bleeding Varices in Cirrhosis [NA]
A completed clinical trial examined transjugular intrahepatic portosystemic shunt (TIPS) versus portacaval shunt for acute esophageal varice…
-
CLINICAL_TRIALS trial_result · 2008-06-19Clinical Trial Update: Liver Transplantation Versus Alternative Therapies for Patients With Pugh B Alcoholic Cirrhosis [NA]
A completed clinical trial compared liver transplantation with alternative therapies for patients with Pugh B alcoholic cirrhosis.
-
CLINICAL_TRIALS trial_result · 2008-05-22Clinical Trial Update: Probiotics for the Prevention of Major Complications of Cirrhosis [NA]
A completed clinical trial sponsored by Meir Medical Center evaluated whether probiotics can prevent major complications in people with live…
-
CLINICAL_TRIALS trial_result · 2008-05-19Clinical Trial Update: Evaluation the Growth Factors(IGF-1,IGFBP-3and HGH)in Patients With Chronic Liver Disease
A completed clinical trial evaluated the effects of growth factors IGF-1, IGFBP-3, and growth hormone (somatropin) in patients with chronic …
-
CLINICAL_TRIALS research · 2008-05-15Clinical Trial Update: Role of Probiotics in the Prevention of Spontaneous Bacterial Peritonitis in Cirrhotic Patients: A Randomized Placebo Control Trial [Phase 2, Phase 3]
A randomized trial update (Phase 2/3) evaluating whether probiotics can prevent spontaneous bacterial peritonitis in patients with liver cir…
-
FDA approval · 2008-04-10FDA Approved: TORSEMIDE — Supplemental Application (Chartwell RX, LLC)
FDA approved Chartwell RX, LLC's supplemental application for Torsemide, enabling the requested changes to the product's approval.
-
CLINICAL_TRIALS trial_result · 2008-04-03Clinical Trial Update: Safety Study of Autologous Stem Cell in Liver Cirrhosis [Phase 1, Phase 2]
A safety-focused Phase 1/Phase 2 clinical trial evaluating autologous stem cell therapy for liver cirrhosis was terminated.
-
CLINICAL_TRIALS trial_result · 2007-11-26Clinical Trial Update: Treatment for Prevention of Variceal Rebleeding Guided by the Hemodynamic Response [Phase 4]
Phase 4 trial evaluates a hemodynamic-response-guided treatment to prevent variceal rebleeding in patients with portal hypertension due to l…
-
CLINICAL_TRIALS research · 2007-10-08Clinical Trial Update: TCM Etiological Study on the Theory of XuSunShengJi in Liver Cirrhosis [NA]
Clinical trial registry entry for a traditional Chinese medicine etiological study in liver cirrhosis sponsored by Shanghai University of Tr…
-
CLINICAL_TRIALS trial_result · 2007-10-03Clinical Trial Update: PiCCO Guided Therapy in Liver Cirrhosis [NA]
A trial evaluating PiCCO-guided therapy for liver cirrhosis has completed.
-
CLINICAL_TRIALS research · 2007-09-17Clinical Trial Update: Echocardiographic Assessment of Intrapulmonary Vasodilatation: Agitated Saline Versus Polygeline
A clinical trial from the Medical University of Vienna comparing agitated saline versus polygeline for echo-based assessment of intrapulmona…
-
CLINICAL_TRIALS trial_result · 2007-09-05Clinical Trial Update: Efficacy of Baclofen in the Treatment of Alcohol Addiction [Phase 1, Phase 2]
Clinical trial update reporting the efficacy of baclofen for treating alcohol use disorder across Phase 1 and Phase 2 studies (completed).
-
CLINICAL_TRIALS research · 2007-07-26Clinical Trial Update: Urotensin II and Vascular Tone in Cirrhosis
This update describes ongoing clinical research on urotensin II and vascular tone in patients with cirrhosis.
-
CLINICAL_TRIALS trial_result · 2007-07-16Clinical Trial Update: Satavaptan Dose-Ranging Study in Normonatraemic Patients With Cirrhotic Ascites [Phase 2]
A Phase 2 dose-ranging trial of satavaptan in normonatraemic patients with cirrhotic ascites has completed.
-
FDA approval · 2007-03-28FDA Approved: FUROSEMIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for furosemide from Hikma Pharmaceuticals USA Inc., resulting in changes to the product labeling…
-
CLINICAL_TRIALS trial_result · 2007-02-09Clinical Trial Update: Efficacy of L-Ornithine-L-Aspartate in Cirrhotics With Hepatic Encephalopathy [Phase 3]
A Phase 3 clinical trial evaluating the efficacy of L-Ornithine-L-Aspartate in cirrhotic patients with hepatic encephalopathy has completed.
-
CLINICAL_TRIALS trial_result · 2006-10-04Clinical Trial Update: Relationship of Vasoactive Peptide Levels to Portal Pressure and Patient Outcomes in Patients With Hepatic Cirrhosis
A completed clinical trial examined the relationship between vasoactive peptide levels, portal pressure, and clinical outcomes in patients w…